Catalyst Wire Dossier Catalyst Wire Dossier

ATROVENT Inhalation Aerosol

ipratropium bromide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATROVENT Inhalation Aerosol, covering 2014-07-17 to 2014-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease [Phase 3]

See pricing